Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Oseltamivir in ESRD Patients on Dialysis
NCT02617784Phase 1Completed
- Sponsor
- Roche
- Start
- Oct 2001
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of oseltamivir in influenza (2 arms), sponsored by Roche. Primary endpoints: Maximum Plasma Concentration of Oseltamivir, Maximum Plasma Concentration of Oseltamivir Carboxylate and 2 more. Started Oct 2001; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02617784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617784.